Marijuana Round-Up: What Happened in Cannabis News in January

Can’t keep track of all the marijuana news? Here’s a round-up of some of the biggest and most interesting stories of the new year, including Aurora Cannabis Inc.’s (TSX:ACB) successful takeover bid.

| More on:

In January, there was a flurry of activity in the Canadian cannabis market. There was so much activity that unless you’re a religious follower, you’ve likely forgotten half of what happened. Let’s review the biggest marijuana news of last month.

The love triangle

One of the biggest “will they or won’t they” stories of the last few months has revolved around Aurora Cannabis Inc. (TSX:ACB), CanniMed Therapeutics Inc. (TSX:CMED), and Newstrike Resources Ltd. (TSXV:HIP). Aurora wanted to merge with CanniMed, but CanniMed wanted to purchase Newstrike instead.

The Newstrike deal got an interesting publicity boost when Canadian rockers the Tragically Hip threw their weight behind the deal. (The band has a +5% stake in Newstrike.) CanniMed considered the Aurora offer to be a hostile bid, so for a while, it seemed the CanniMed/Newstrike deal would be the one to survive. Surprise! Aurora and CanniMed came to friendly terms on January 24 after Aurora considerably sweetened its bid. This also put the kibosh on the Newstrike plan. (The deal is not yet finalized.)

Aurora also announced on January 29 that is has received a licence from Health Canada for its third facility, Aurora Sky, which currently being built in Edmonton. When completed, it will be an 800,000-square-foot hybrid greenhouse.

It’s been a good month for Aurora.

Where does that leave Newstrike? It’s not happy, and its deal with The Hip doesn’t look as good now that the band won’t be producing any more music or touring, lessening their promotion capabilities. The company did receive a $9.5 million break fee from the fallen-through deal and raised more than $90 million right after the Aurora/CanniMed deal was announced through a private share placement, so not all the news is bad.

The newest kid on the block

Since individual marijuana stocks have been piping hot over the last few years, the market decided marijuana needs its own exchange-traded funds. The first Canadian actively managed ETF began trading on February 1 under the ticker MJJ. It’s the Marijuana Opportunities Fund operated by Redwood Asset Management. HORIZNS MARIJUNA LF CL A UNT ETF (TSX:HMMJ) already has a marijuana ETF, but it is not actively managed. That fund gathered over $100 million is assets in just one month, so expect this new ETF to do a brisk business.

The U.S. market

Canadian cannabis marijuana producers have been worried since a TSX announcement last year that it could de-list any stocks that breached federal laws. Canadian Securities administrators are still reviewing their policies around this issue. Aphria Inc. (TSX:APH) is worried enough that it is beating a retreat from the U.S. market. The company is planning to sell its non-controlling stake in an Arizona medical cannabis producer for a start.

Any other issues on the horizon?

In what seems like unrelated news, the Canadian Senate forced through an approval to make Canada’s national anthem gender neutral at the end of January. The Conservative caucus was unimpressed with the procedure and is now threatening to hold up other legislation important to the Liberal government, including the new marijuana laws. If they make good on their threat, the Conservatives could force a pushback in the July 2018 legalization date. Stay tuned for more information on that front.

Investor takeaway

We’ve got plenty of other stories on the marijuana market here at the Motley Fool. For a general round-up, check out this article about marijuana prices by Fool contributor Chris MacDonald, and this article by Fool contributor Demetris Afxentiou about which stocks might soar when legalization happens this year. The one thing I can promise is the industry will continue to be a news generator throughout 2018.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Susan Portelance has no position in any stocks mentioned.

More on Investing


CNR Stock: Should You Buy Today?

Canadian National Railway has been hit in recent quarters, as economic growth has slowed, with CNR stock declining 10% in…

Read more »

Family relationship with bond and care
Dividend Stocks

TFSA Investors: 3 Cheap Canadian Stocks for Retirees

These three Canadian stocks are super cheap for retirees looking for a great buy that will last the test of…

Read more »

calculate and analyze stock
Dividend Stocks

CPP Disability Benefits: Here’s How Much You Could Get

Not everybody can get CPP disability benefits. If you want some passive income, consider investing in Royal Bank of Canada…

Read more »

growing plant shoots on stacked coins
Dividend Stocks

Boosting Your Monthly Income: TSX Stocks That Deliver

Dividend investing can boost regular or active incomes, especially select TSX stocks that pay monthly dividends.

Read more »

consider the options
Tech Stocks

Better Buy (2024 Edition): Shopify or Nvidia Stock?

Shopify (TSX:SHOP) isn't the only red-hot tech stock in town that could add to recent gains.

Read more »

Bad apple with good apples

5 Stocks You Can Confidently Invest $500 in Right Now

These stocks could significantly grow your investment over the next decade.

Read more »

Illustration of bull and bear
Tech Stocks

A Bull Market Is Coming: 3 Growth Stocks That Could Thrive

Given their high growth prospects and cheaper valuation, these three growth stocks would be an excellent buy as the market…

Read more »

Golden crown on a red velvet background
Energy Stocks

Enbridge Stock: This Dividend Aristocrat Could Gain in 2024

Enbridge (TSX:ENB) stock is looking like a great buy as management expects it to grow in 2024.

Read more »